The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

People

Dr Renate Schwab


Dr Renate Schwab is a junior post-doc in the Molecular Oncology research group headed by Professor Elizabeth Vincan. Renate has extensive research expertise with mouse and human models of colon cancer, with a focus on Wnt signalling, a molecular pathway that is critical for stem cell function. Renate completed her PhD in the Vincan group, studying the function of a Wnt receptor, Frizzled7, at the initiation of colon cancer and during tumour morphogenesis. Renate developed novel ex-vivo 3D tumour organoid technologies to dissect the transition from stem cell to cancer stem cell.

  • Research Groups
    • Vincan Group

      Elizabeth’s group investigates novel ways to block cancer growth with a focus on the gastrointestinal tract – stomach, bowel and liver. A cell-cell communication pathway called Wnt is hyperactive in these cancers. Their research shows inhibiting Wnt has potent anti-cancer effects.


      Lab Team

      Vincan Group

Full University of Melbourne profile